Does Semantic Long-Term Memory Impact Refreshing in Verbal Working Memory?
V. Camos; G. Mora; A.L. Oftinger; S.Mariz Elsig; P. Schneider; E. Vergauwe
2019 |
10.1037/xlm0000657 |
Does Sound Influence Perceived Duration of Visual Motion?
A. Carlini; E. Bigand
2021 |
10.3389/fpsyg.2021.751248 |
Does student employment really impact academic achievement? The case of France
K.MarieDani Body; L. Bonnal; J.F. Giret
2014 |
10.1080/00036846.2014.920483 |
Does the French Big Five Inventory evaluate facets other than the Big Five factors?
R. Courtois; J.M. Petot; B. Lignier; G. Lecocq; O. Plaisant
2018 |
10.1016/j.encep.2017.02.004 |
DOES THE INTRA-GASTRIC BALLOON INCREASE REFLUX DESPITE WEIGHT LOSS?
S.A. Barrichello; D. Badurdeen; A. Hedjoudje; L. Fayad; M.Galvao Neto; A. Veinert; E. Grecco; T.F. Souza; C. Simsek; M.A. Khashab; A.N. Kalloo; V. Kumbhari
2019 |
10.1016/j.gie.2019.03.301 |
Does the Literature Support a High Willingness to Pay for Green Label Buildings? An Answer with Treatment of Publication Bias
F. Fizaine; P. Voye; C. Baumont
2018 |
10.3917/redp.285.1013 |
Does the Presence of Neuropathic Pain Influence the Response to Hyaluronic Acid in Patients with Knee Osteoarthritis?
E. Tiendrebeogo; M. Choueiri; X. Chevalier; T. Conrozier; F. Eymard
2021 |
10.1177/1947603520954509 |
DOES THE PROPORTION OF SINGLE-CHAIN RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR INFLUENCE OUTCOMES IN PATIENTS WITH CEREBRAL ISCHEMIA?
C. Jacquet; D. Leys; Y. Hommet; I. Sibon; J.L. Mas; T. Moulin; M. Giroud; R. Bordet; D. Vivien
2016 |
|
DOES THE PROPORTION OF SINGLE-CHAIN RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR INFLUENCE OUTCOMES IN PATIENTS WITH CEREBRAL ISCHEMIA?
C. Jacquet; D. Leys; Y. Hommet; I. Sibon; J.L. Mas; T. Moulin; M. Giroud; R. Bordet; D. Vivien
2016 |
|
Does the proportion of single-chain rtPA influence outcomes in patients with cerebral ischemia?
D. Leys; I. Sibon; J.L. Mas; T. Moulin; M. Giroud; R. Bordet; D. Vivien
2016 |
|
Does the proportion of single-chain rtPA influence the risk of epileptic seizures in patients treated by thrombolytic therapy for cerebral ischemia?
C. Jacquet; D. Leys; I. Sibon; J.L. Mas; T. Moulin; M. Giroud; R. Bordet; D. Vivien
2016 |
|
Does the proportion of single-chain rtPA influence the risk of epileptic seizures in patients treated by thrombolytic therapy for cerebral ischemia?
C. Jacquet; D. Leys; I. Sibon; J.L. Mas; T. Moulin; M. Giroud; R. Bordet; D. Vivien
2016 |
|
Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and overtime? A pooled analysis of 610 RCTs published between 2004 and 2018.
F. Sparano; N.K. Aaronson; M.A.G. Sprangers; P. Fayers; A. Pusic; J.M. Kieffer; J. Rees; C. Wan; M. Pezold; S. Fuzesi; S. Isharwal; A. Anota; E. Charton; M. Vignetti; F. Cottone; J.M. Blazeby; F. Efficace
2019 |
10.1200/JCO.2019.37.15_suppl.e18218 |
Does the surgical approach for treating mandibular condylar fractures affect the rate of seventh cranial nerve injuries? A systematic review and meta-analysis based on a new classification for surgical approaches
E.Ahmed Al-Moraissi; A. Louvrier; G. Colletti; L.M. Wolford; F. Biglioli; M. Ragaey; C. Meyer;
2018 |
10.1016/j.jcms.2017.10.024 |
Does the thought of death contribute to the memory benefit of encoding with a survival scenario?
A. Bugaiska; M. Mermillod; P. Bonin
2015 |
10.1080/09658211.2014.881881 |
Does the treatment with recombinant human growth hormone improve final height in patients affected by X-linked hypophosphatemia?
J. Andre; V.V. Zhukouskaya; A. Rothenbuhler; A.S. Lambert; J.P. Salles; B. Mignot; A. Linglart
2019 |
|
Does the treatment with recombinant human growth hormone improve final height in patients affected by X-linked hypophosphatemia?
J. Andre; V.V. Zhukouskaya; A. Rothenbuhler; A.S. Lambert; J.P. Salles; B. Mignot; A. Linglart
2019 |
|
Does the weather play a role in the spread of pandemic influenza? A study of H1N1pdm09 infections in France during 2009-2010
M. Vittecoq; B. Roche; J.M. Cohen; F. Renaud; F. Thomas; M. Gauthier-Clerc
2015 |
10.1017/S0950268815000941 |
Does thrombo-aspiration still have a place in the treatment of myocardial infarction?
F. Schiele; F. Ecarnot
2016 |
10.1186/s12872-016-0291-6 |
Does Ticagrelor Decrease the Risk of Recurrent Fatal or Non-Fatal Myocardial Infarction in Real-World Settings? The AReMIS (Antiplatelet agents and Recurrent Myocardial Infarction Study) Case-Cohort Study
L. Grimaldi-Bensouda; N. Danchin; J. Dallongeville; B. Falissard; A. Furber; Y. Cottin; L. Bonello; O. Morel; F. Leclercq; E. Puymirat; F. Ghanem; J. Benichou; L. Abenhaim
2017 |
|
Does ticagrelor decrease the risk of recurrent fatal or non-fatal myocardial infarction in real-world settings? The AReMIS case-cohort study
L. Grimaldi-Bensouda; N. Danchin; J. Dallongeville; B. Falissard; A. Furbers; Y. Cottin; L. Bonello; O. Morels; F. Leclercq; E. Puymirat; F. Ghanem; J. Benichou; L. Abenhaim; P.G.R.M.I.Study Grp
2017 |
|
Does ticagrelor decrease the risk of recurrent fatal or non-fatal myocardial infarction in real-world settings? The AReMIS case-cohort study
L. Grimaldi-Bensouda; N. Danchin; J. Dallongeville; B. Falissard; A. Furbers; Y. Cottin; L. Bonello; O. Morels; F. Leclercq; E. Puymirat; F. Ghanem; J. Benichou; L. Abenhaim; P.G.R.M.I.Study Grp
2017 |
|
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
G. Rocher; T. Gaillard; C. Uzan; P. Collinet; P.A. Bolze; M. Ballester; S. Bendifallah; L. Ouldamer; C. Touboul; C. Huchon; V. Lavoue; Y. Dabi; C. Akladios; C. Coutant; E. Raimond; A. Bricou; G. Canlorbe; H. Azais
2021 |
10.3390/jcm10051058 |
Does tocilizumab indeed reduce the frequency of Th17 cells? Comment on the article by Thiolat et al
M. Samson; S. Audia; P. Ornetti; J.F. Maillefert; N. Janikashvili; B. Bonnotte
2014 |
10.1002/art.38718 |
Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?
M. Samson; B. Bonnotte
2018 |
10.1016/j.revmed.2017.11.003 |
